Breaking News
USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS
INDEGENE AND CONTIPI MEDICAL LTD FORGE PARTNERSHIP
EU AND ITALY NOT EXPORTING ASTRAZENECA VACCINE TO AUSTRALIA
MEDTECS AND ACO INTERNATIONAL TO START JOINT VENTURE
Skip to content
  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
Medgazette 24

Medgazette 24

Healthcare Latest news, Medical Technology Updated News

  • Home
  • Healthcare
  • Medicine
  • Pharamaceuticals
  • Research
  • Home
  • AstraZeneca

Tag: AstraZeneca

EU AND ITALY NOT EXPORTING ASTRAZENECA VACCINE TO AUSTRALIA

March 12, 2021March 12, 2021 medgazettePharamaceuticals

HIGHLIGHTS EU and Italy are no longer exporting Astrazeneca vaccine to Australia. Europe is citing shortage of vaccine to justify refusal to export. The export of a shipment of more than a quarter million AstraZeneca vaccines destined for Australia has…

FRANCE BEGINS DISTRIBUTING COVID VACCINE AMID UK VARIANT WARNING

February 24, 2021 medgazetteNews

HIGHLIGHTS France is distributing the AstraZeneca’s COVID-19 vaccine. As epidemiologist Arnaud Fontanet warned about possibility of coronavirus variant B.1.1.7 from UK dominating Franceby MAR 2021. France has started distributing the AstraZeneca’s COVID-19 vaccine as epidemiologist Arnaud Fontanet warned the government…

ASTRAZENECA DEPLOYS CARE ACCESS RESEARCH TOOL FOR COVID-19 TREATMENT CLINICAL TRIAL

February 1, 2021February 3, 2021 medgazetteResearch

HIGHLIGHTS AstraZeneca and Care Access Research have forged a partnership to support the Phase III clinical trial for AZD7442. AZD7442 has been developed by AstraZeneca as an attempt to prevent COVID-19. AZD7442 is a monoclonal antibody combination. Participants for this…

EU AUTHORIZES ASTRAZENECA’S COVID-19 VACCINE FOR ADULTS THROUGHOUT 27 NATIONS

January 31, 2021 medgazetteNews

Highlights – EU authorizes AstraZeneca’s COVID-19 vaccine for adults throughout 27 nations. The European Medicines Agency unanimously recommended the vaccine to be used. The vaccine is said to be 60% effective, in comparison to Pfizer and Moderna’s vaccine. The vaccine…

Movantik Rights Divested To RedHill By AZ

February 26, 2020February 26, 2020 Shreyas TannaNews, Pharamaceuticals

The British-Swedish pharma giant AstraZeneca (AZ) has decided to sublicense its global rights to Movantik (naloxegol) to RedHill Biopharma. However, AZ has said that it will continue to manufacture and supply the chronic non-cancer pain drug to RedHill during a…

The triple-combination therapy of AstraZeneca is approved for COPD in China

The triple-combination therapy of AstraZeneca is approved for COPD in China

January 6, 2020 Shreyas TannaNews, Research

AstraZeneca has confirmed that budesonide / glycopyrronium / formoterol fumarate has been approved for chronic obstructive pulmonary disease (COPD) rehabilitation treatment in China. This is the National Medical Products Administration’s first certification for a triple-combination therapy in a pressurized metered-dose…

AstraZeneca Tops the First Pharmaceutical Invention Index

AstraZeneca Tops the First Pharmaceutical Invention Index

November 7, 2019 Shreyas TannaNews, Pharamaceuticals

The primary yearly Pharmaceutical Invention Index, discharged by IDEA Pharma today, sees AstraZeneca top the business for the curiosity and broadness of its pipeline. Discharged without precedent for 2019, at the Pharma Innovation Summit in Boca Raton, FL, the Pharmaceutical…

Shionogi forms their own staff in the United States

July 19, 2019 Purvesh JainNews

Japan’s Shionogi and Co Ltd <4507.T> has played safe when selling its medications in the United States and different abroad markets – depending on greater accomplices to advance its items and evading the expense of keeping up an enormous deals…

Extension of overall Survival of patients with SCLC by Imfinzi Combo Therapy

July 8, 2019 Purvesh JainNews

According to the results of phase III clinical trial, by the addition of Imfinzi to the standard first-line chemotherapy resulted in the clinically meaningful extension in the overall survival rate of the patients who have advanced small cell lung cancer…

Recent News

IBS AND THE ROYAL SOCIETY TO COOPERATE ON COVID-19

March 3, 2021

SANOFI TO PRODUCE JOHNSON & JOHNSON’S COVID-19 VACCINE IN FRANCE

March 2, 2021

HIKMA DONATES OVER 4 MILLION USD IN MEDICINES

March 1, 2021

USFDA APPROVES POTASSIUM CHLORIDE ER CAPSULES FROM GRANULES INDIA

February 26, 2021

ONWARD THERAPEUTICS AND BIOMUNEX PHARMACEUTICALS SIGN NEW AGREEMENT

February 25, 2021

FRANCE BEGINS DISTRIBUTING COVID VACCINE AMID UK VARIANT WARNING

February 24, 2021

UK HEALTHCARE KENTUCKY’S FIRST EXCELLENT SYSTEM FOR HIDDEN SCAR BREAST CANCER SURGERY

February 23, 2021

RAMONA SEQUEIRA MAY SOON BE CHAIRPERSON OF PHRMA BOARD

February 22, 2021

UK GOVERNMENT EXTENDS WOCKHARDT’S CONTRACT CREATING NEW JOBS

February 19, 2021

ARTIOS PHARMA ANNOUNCES FIRST CLINICAL STUDY REGARDING ADVANCED NEXT-GEN DDR

February 18, 2021

Categories

  • Healthcare
    • Healthcare IT
  • Medicine
  • News
  • Pharamaceuticals
  • Research
Medicine
March 16, 2021

USFDA APPROVES INFLUENZA VACCINE FROM SEQIRUS

HIGHLIGHTS USFDA has approved the expanded age indication of cell-based Quadrivalent influenza…

Medicine
March 10, 2021

GERMANY’S MERCK SIGNS AGREEMENT FOR HEAD AND NECK CANCER DRUG

HIGHLIGHTS Merck has signed an agreement with Debiopharm. This is a €…

  • About Us
  • Authors
  • Contact Us
Copyright © All rights reserved.
Powered by WordPress | Magazine Point by Axle Themes